212 related articles for article (PubMed ID: 28723227)
1. Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders.
Murphy TK; Fernandez TV; Coffey BJ; Rahman O; Gavaletz A; Hanks CE; Tillberg CS; Gomez LI; Sukhodolsky DG; Katsovich L; Scahill L
J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):762-770. PubMed ID: 28723227
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
Scahill L; Chappell PB; Kim YS; Schultz RT; Katsovich L; Shepherd E; Arnsten AF; Cohen DJ; Leckman JF
Am J Psychiatry; 2001 Jul; 158(7):1067-74. PubMed ID: 11431228
[TBL] [Abstract][Full Text] [Related]
3. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
Boon-yasidhi V; Kim YS; Scahill L
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
[TBL] [Abstract][Full Text] [Related]
4. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.
Scahill L; McCracken JT; King BH; Rockhill C; Shah B; Politte L; Sanders R; Minjarez M; Cowen J; Mullett J; Page C; Ward D; Deng Y; Loo S; Dziura J; McDougle CJ;
Am J Psychiatry; 2015 Dec; 172(12):1197-206. PubMed ID: 26315981
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Wilens TE; Robertson B; Sikirica V; Harper L; Young JL; Bloomfield R; Lyne A; Rynkowski G; Cutler AJ
J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):916-25.e2. PubMed ID: 26506582
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
Hervas A; Huss M; Johnson M; McNicholas F; van Stralen J; Sreckovic S; Lyne A; Bloomfield R; Sikirica V; Robertson B
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1861-72. PubMed ID: 25453486
[TBL] [Abstract][Full Text] [Related]
7. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
Stein MA; Sikirica V; Weiss MD; Robertson B; Lyne A; Newcorn JH
CNS Drugs; 2015 Nov; 29(11):953-62. PubMed ID: 26547425
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
Cui YH; Zheng Y; Yang YP; Liu J; Li J
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
[TBL] [Abstract][Full Text] [Related]
10. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
[TBL] [Abstract][Full Text] [Related]
11. Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.
Strawn JR; Compton SN; Robertson B; Albano AM; Hamdani M; Rynn MA
J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):29-37. PubMed ID: 28165762
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
Wilens TE; Bukstein O; Brams M; Cutler AJ; Childress A; Rugino T; Lyne A; Grannis K; Youcha S
J Am Acad Child Adolesc Psychiatry; 2012 Jan; 51(1):74-85.e2. PubMed ID: 22176941
[TBL] [Abstract][Full Text] [Related]
15. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.
Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R
J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474
[TBL] [Abstract][Full Text] [Related]
16. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
[TBL] [Abstract][Full Text] [Related]
17. Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.
Kollins SH; López FA; Vince BD; Turnbow JM; Farrand K; Lyne A; Wigal SB; Roth T
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):111-20. PubMed ID: 21476931
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
Newcorn JH; Stein MA; Childress AC; Youcha S; White C; Enright G; Rubin J
J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):921-30. PubMed ID: 23972694
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.
Davis LL; Ward C; Rasmusson A; Newell JM; Frazier E; Southwick SM
Psychopharmacol Bull; 2008; 41(1):8-18. PubMed ID: 18362867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
